Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT03930914 · ClinicalTrials.gov registry record · NA
Vagus Nerve Stimulation in Treatment of Postural Orthostatic Tachycardia Syndrome
A NA study, sponsored by University of Oklahoma.
- Completed
- Registry status
- NA
- Development phase
- 5
- Enrollment target
NCT03930914 is a NA study that has completed, run by University of Oklahoma. The registered enrollment target is 5 participants.
The verdict
NCT03930914, a NA study, has completed, sponsored by University of Oklahoma.
- COMPLETED
- Registry status
- NA
- Development phase
- 5 participants
- Enrollment target
Study Summary
Postural orthostatic tachycardia (POTS) is characterized by abnormalities in the autonomic nervous system in the body. The autonomic nervous system controls and regulates body functions such as heart rate, breathing, digestion, and more. The investigator has shown that patients with POTS have higher cardiovascular and adrenergic activating autoantibodies (AAb), which likely changes the normal make-up of POTS. There are autoantibodies that have been suggested by a few reports of their presence in POTS, but their role different aspects of POTS is unknown. The study will look at the body's responses in patients with POTS. The crossover study design is to have half of the patients will start with sham followed by active stimulation and half will start by active followed by sham stimulation. It is anticipated that results will provide a potential therapeutic approach based on the understanding of POTS.
Interventions
- DEVICE Parasym (TM) Transcutaneous Electrical Nerve Stimulation (TENS) Device
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 5 participants |
| Start Date | 2019-11-04 |
| Est. Completion | 2021-12-07 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT03930914
The ClinicalTrials.gov registry entry for NCT03930914 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 5 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is University of Oklahoma, which has 358 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 1 intervention - of which Parasym (TM) Transcutaneous Electrical Nerve Stimulation (TENS) Device is the first listed.
NCT03930914 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT03930914 about?
NCT03930914 is a clinical study titled "Vagus Nerve Stimulation in Treatment of Postural Orthostatic Tachycardia Syndrome". Postural orthostatic tachycardia (POTS) is characterized by abnormalities in the autonomic nervous system in the body. The autonomic nervous system controls and regulates body functions such as heart rate, breathing, digestion, and more. The investigator has shown that patients with POTS have highe...
What is the current status of trial NCT03930914?
This trial is currently completed. It is a NA study. The enrollment target is 5 participants. The study started on 2019-11-04. Estimated completion is 2021-12-07.
What interventions are being tested in trial NCT03930914?
The interventions under investigation include: Parasym (TM) Transcutaneous Electrical Nerve Stimulation (TENS) Device (DEVICE).
Who is sponsoring clinical trial NCT03930914?
This trial is sponsored by University of Oklahoma, which has 358 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.